T1/T2 Research (Bedside/Bench)
T1/T2; developing therapeutic strategies
targeted to patient and cancer biomarkers. A translational research
program linking the biosciences, clinical trials and
Sydney Catalyst will link basic sciences
discoveries, with novel early phase clinical trials through to
better personalised patient care. We will identify subpopulations
of patients who will benefit most from particular treatment by
using in vitro diagnostics to determine their molecular phenotype
individual cancer to guide therapeutic decisions. Laboratory assays
will be linked to patient cohorts within our hospitals and with
ongoing and future controlled trials.
Details of Sydney Catalyst funded T1/T2
research to date can be found in the links below:
To read about projects that cross both the T1/T2 and T2/T3
research streams click here.